Sentinel Lymph Node Biopsy: Clinical Trials

9 trials of Sentinel Lymph Node Biopsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 9 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 4, Recruiting 2, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 22Completed 1, Recruiting 1

Follow Sentinel Lymph Node Biopsy: new trials by email Literature Review of Sentinel Lymph Node Biopsy trials Research Report on Sentinel Lymph Node Biopsy

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sentinel Lymph Node Biopsy (SLNB), Doxorubicin, Epirubicin - Breast Neoplasms
Phase 1RecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University242023-11-012023-11-08
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sentinel Lymph Node Biopsy (SLNB), Doxorubicin, Epirubicin - Breast Neoplasms
Phase 1 / Phase 2RecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University1962023-08-012023-08-08
Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma
Sentinel Lymph Node Biopsy, Ultrasonography, Sonazoid - Cutaneous Melanoma, Melanoma
Phase 1TerminatedUniversity of Southern California52017-04-262020-03-30
Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer
Sipuleucel-T, Lymph Node Biopsy - Prostate Cancer
Phase 1CompletedDuke University202014-03-012020-03-31
NIR-Guided Sentinel Lymph Node Mapping in Melanoma
ICG Intervention - Melanoma
Phase 1CompletedDana-Farber Cancer Institute262010-09-012017-02-03
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
riluzole, polymorphism analysis, axillary lymph node biopsy - Breast Cancer
Phase 1WithdrawnBarbara Ann Karmanos Cancer Institute2009-05-012013-04-29
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
Near Infrared Imaging - Lung Cancer
Phase 1Active not recruitingDana-Farber Cancer Institute572009-02-182025-11-10
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
fludeoxyglucose F 18, positron emission tomography, computed tomography - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)3842007-09-012019-07-23
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
therapeutic autologous lymphocytes, cyclophosphamide, aldesleukin - B-cell Chronic Lymphocytic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
Phase 1CompletedFred Hutchinson Cancer Center122007-08-012014-08-06

Conditions studied

Breast Neoplasms (3)  ·  Melanoma (2)  ·  Endometrial Neoplasms (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)  ·  Waldenstrom Macroglobulinemia (1)

Sponsors

Dana-Farber Cancer Institute (2)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Duke University (1)  ·  Fred Hutchinson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  University of Southern California (1)

Countries

United States (6)  ·  China (2)  ·  Canada (1)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Erwei Song, M.D., Ph.D. (2)  ·  Brant Inman, MD (1)  ·  Brian Till (1)  ·  David H. Gorski, MD, PhD, FACSw (1)  ·  Kevin King, MD (1)  ·  Mostafa Atri (1)  ·  Yolonda Colson, MD, PhD (1)  ·  Yolonda L. Colson, MD, PhD (1)

Results publications

PMID 22308288

NIH funding

P30CA014089 (1), P30CA022453 (1), U10CA027469 (1), U10CA180868 (1)